3 ms·
Interesting its cheaper than mRNA, i thought that was one of the benefits of using mRNA, was that it was supposed to be cheaper to manufacture.
by bawolff 6y ago
Interesting its cheaper than mRNA, i thought that was one of the benefits of using mRNA, was that it was supposed to be cheaper to manufacture.
- disgruntledphd2 6y agoI don't know much about the chemistry, but most new processes tend to be more expensive due to setup costs.
- andylynch 6y agoIn theory mRNA will be, but it’s a new technology so still going to be more expensive to start with. The other major benefit is that these vaccines can be developed more quickly, which is worthwhile in its own right.
- garmaine 6y agoI don’t know why mRNA would be cheaper to manufacture. It is far less stable and therefore harder to work with.
- lultimouomo 6y agoMy understanding (which might very well be ridiculously wrong) is that mRNA vaccines are a bit like 3d printing; it is incredibly faster and cheaper to build a single one-off item, but if you need to mass produce you still want to go with injection moulding.
- fabian2k 6y agoOne big difference is that RNA is more generic. Within certain parameters it doesn't matter which specific RNA sequence you produce, it always works the same way and you can use the same facilities for this. There are potential cost advantages there, if you can use a generic, validated process to produce different types of vaccines or drugs without having to develop, tune and certify the core production from scratch every time. I don't know the economics here, but I would assume that cost advantages are much more likely to appear for small-scale products here than what we have now, producing a billion doses in large factories.
- OJFord 6y agoIf you're manufacturing something and selling it at a profit, that's absolutely a benefit! I don't know that the manufacturing costs are less (for Pfizer, Moderna), but I think it's a fair assumption that the bulk of the difference is AstraZeneca (currently) providing it at cost.